A non-invasive test for receptor binding applied to nephrogenic diabetes insipidus
- PMID: 196275
- PMCID: PMC2496684
- DOI: 10.1136/pgmj.53.621.374
A non-invasive test for receptor binding applied to nephrogenic diabetes insipidus
Abstract
Studies in animals have determined the importance of specific receptors to the action of many hormones and drugs. In man, a non-invasive external counting technique has been used and absence of receptor function has been demonstrated in a patient with nephrogenic diabetes insipidus using radioactively labelled arginine vasopressin. This is in contrast to the findings in a patient with pituitary diabetes insipidus and a normal control. These results suggest a model for the study of hormone and drug kinetics in man avoiding multiple samplings of biological fluids.
Similar articles
-
Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.Eur J Pediatr. 1992 May;151(5):381-3. doi: 10.1007/BF02113263. Eur J Pediatr. 1992. PMID: 1396896
-
Altered catecholamine innervation of the supraoptic nucleus in the nephrogenic diabetes insipidus mouse.Neuroendocrinology. 1985 Nov;41(5):394-9. doi: 10.1159/000124208. Neuroendocrinology. 1985. PMID: 3903537
-
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.N Engl J Med. 1988 Apr 7;318(14):881-7. doi: 10.1056/NEJM198804073181403. N Engl J Med. 1988. PMID: 2965301
-
[Diabetes insipidus: etiology, diagnosis, and therapy].Orv Hetil. 2002 Nov 17;143(46):2579-85. Orv Hetil. 2002. PMID: 12520852 Review. Hungarian.
-
Genetics of Diabetes Insipidus.Endocrinol Metab Clin North Am. 2017 Jun;46(2):305-334. doi: 10.1016/j.ecl.2017.01.002. Epub 2017 Feb 28. Endocrinol Metab Clin North Am. 2017. PMID: 28476225 Review.